Skip to content

Drug interactions

Lasmiditan + Pazopanib

Severity: Moderate

Lasmiditan and Pazopanib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lasmiditan inhibits P-glycoprotein and BCRP in vitro, and pazopanib is a substrate of both transporters. Exposure to pazopanib could rise, increasing the risk of adverse effects.

What this interaction means in plain words

Lasmiditan and Pazopanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lasmiditan belongs to Central Nervous System; Pazopanib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of intestinal P-gp and BCRP efflux by lasmiditan, increasing pazopanib absorption.

What to do

Consider an alternative acute migraine treatment during pazopanib therapy. If used, monitor for pazopanib toxicity including liver tests and blood pressure.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lasmiditan and Pazopanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lasmiditan with Pazopanib?

MediHelp rates the interaction as moderate. Lasmiditan and Pazopanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lasmiditan inhibits P-glycoprotein and BCRP in vitro, and pazopanib is a substrate of both transporters. Exposure to pazopanib could rise, increasing the risk of adverse effects.

How serious is the interaction between Lasmiditan and Pazopanib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider an alternative acute migraine treatment during pazopanib therapy. If used, monitor for pazopanib toxicity including liver tests and blood pressure.

What other medicines interact with Pazopanib?

MediHelp also lists interactions of Pazopanib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Pazopanib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in